- Ian Sheerin
- Peter Davidson
- Chris Frampton
Supported by Canterbury Neurological Trust
All new cases of kidney stone disease in Canterbury during 2002 were identified and costs were investigated for health care and social burden. The results will estimate community prevalence of kidney stone disease and the social and economic costs involved. These include health care costs, investigations, hospitalisations, interventions, pharmaceuticals, lost work days, missed social events and the effects on partners and carers. There are no other published studies on the burden of kidney stone disease in a defined community and it is expected that this research will indicate the major sources of costs arising from kidney stones, which are increasing in prevalence and which mainly affect people of working ages.
Davidson PJ, Sheerin IG, Frampton C. Renal stone disease in Christchurch, New Zealand. Part 1: presentation and epidemiology. New Zealand Medical Journal 122(1297), 2009.
Davidson PJ, Sheerin IG, Frampton C. Renal stone disease in Christchurch, New Zealand. Part 2: a community study on the burden of renal stone disease. New Zealand Medical Journal 122(1297), 2009.